ALSALLOUM et al.1030
BIOCHEMISTRY (Moscow) Vol. 89 No. 6 2024
Transm. (Vienna), 126, 481-516, doi: 10.1007/s00702-
018-1957-2.
19. Poisson, C.L., Engel,L., and Saunders, B.T. (2021) Do-
pamine circuit mechanisms of addiction-like behav-
iors, Front. Neural Circuits, 15, 752420, doi: 10.3389/
fncir.2021.752420.
20. Kobayashi, K., Morita, S., Sawada, H., Mizuguchi, T.,
Yamada, K., Nagatsu, I., Hata, T., Watanabe, Y., Fu-
jita, K., and Nagatsu, T. (1995) Targeted disruption
of the tyrosine hydroxylase locus results in severe
catecholamine depletion and perinatal lethality in
mice, J. Biol. Chem., 270, 27235-27243, doi: 10.1074/
jbc.270.45.27235.
21. Kobayashi, K., Noda, Y., Matsushita, N., Nishii, K.,
Sawada, H., Nagatsu, T., Nakahara, D., Fukabori, R.,
Yasoshima, Y., Yamamoto, T., Miura, M., Kano, M.,
Mamiya, T., Miyamoto, Y., and Nabeshima, T. (2000)
Modest neuropsychological deficits caused by re-
duced noradrenaline metabolism in mice hetero-
zygous for a mutated tyrosine hydroxylase gene,
J. Neurosci., 20, 2418-2426, doi: 10.1523/JNEUROSCI.
20-06-02418.2000.
22. Bademci, G., Vance, J. M., and Wang, L. (2012) Ty-
rosine hydroxylase gene: another piece of the
genetic puzzle of Parkinson’s disease, CNS Neu-
rol Disord Drug Targets, 11, 469-481, doi: 10.2174/
187152712800792866.
23. Nagatsu, T., Nakashima, A., Ichinose, H., and Ko-
bayashi, K. (2019) Human tyrosine hydroxylase in
Parkinson’s disease and in related disorders, J. Neu-
ral Transm. (Vienna), 126, 397-409, doi: 10.1007/
s00702-018-1903-3.
24. Kobayashi,K., and Nagatsu,T. (2005) Molecular genet-
ics of tyrosine 3-monooxygenase and inherited dis-
eases, Biochem. Biophys. Res. Commun., 338, 267-270,
doi:10.1016/j.bbrc.2005.07.186.
25. Asmus, F., and Gasser, T. (2010) Dystonia-plus syn-
dromes, Eur. J. Neurol., 17, 37-45, doi: 10.1111/
j.1468-1331.2010.03049.x.
26. Lee, W. W., and Jeon, B. S. (2014) Clinical spectrum
of dopa-responsive dystonia and related disorders,
Curr. Neurol Neurosci. Rep., 14, 461, doi: 10.1007/
s11910-014-0461-9.
27. Dong, H. Y., Feng, J. Y., Yue, X. J., Shan, L., and Jia,
F.Y. (2020) Dopa-responsive dystonia caused by tyro-
sine hydroxylase deficiency: three cases report and
literature review, Medicine (Baltimore), 99, e21753,
doi:10.1097/MD.0000000000021753.
28. Craddock, N., Davé, S., and Greening, J. (2001) Asso-
ciation studies of bipolar disorder, Bipolar Disord.,
3, 284-298, doi:10.1034/j.1399-5618.2001.30604.x.
29. Beaulieu, J.M., Zhang,X., Rodriguiz, R.M., Sotnikova,
T.D., Cools, M.J., Wetsel, W.C., Gainetdinov, R.R., and
Caron, M. G. (2008) Role of GSK3 beta in behavioral
abnormalities induced by serotonin deficiency, Proc.
Natl. Acad. Sci. USA, 105, 1333-1338, doi: 10.1073/
pnas.0711496105.
30. Kulikova, E.A., and Kulikov, A.V. (2019) Tryptophan
hydroxylase 2 as a therapeutic target for psychiat-
ric disorders: focus on animal models, Expert Opin.
Ther. Targets, 23, 655-667, doi:10.1080/14728222.2019.
1634691.
31. Fitzpatrick, P. F. (2023) The aromatic amino acid hy-
droxylases: structures, catalysis, and regulation of
phenylalanine hydroxylase, tyrosine hydroxylase,
and tryptophan hydroxylase, Arch. Biochem. Biophys.,
735, 109518, doi:10.1016/j.abb.2023.109518.
32. Popova, N.K., Kulikov, A.V., Kondaurova, E.M., Tsyb-
ko, A. S., Kulikova, E. A., Krasnov, I. B., Shenkman,
B. S., Bazhenova, E. Y., Sinyakova, N. A., and Nau-
menko, V. S. (2015) Risk neurogenes for long-term
spaceflight: dopamine and serotonin brain system,
Mol. Neurobiol., 51, 1443-1451, doi: 10.1007/s12035-
014-8821-7.
33. Naumenko, V.S., Osipova, D.V., Kostina, E.V., and Ku-
likov, A.V. (2008) Utilization of a two-standard system
in real-time PCR for quantification of gene expres-
sion in the brain, J. Neurosci. Methods, 170, 197-203,
doi:10.1016/j.jneumeth.2008.01.008.
34. Moskaliuk, V. S., Kozhemyakina, R. V., Bazovkina,
D. V., Terenina, E., Khomenko, T. M., Volcho, K. P.,
Salakhutdinov, N. F., Kulikov, A. V., Naumenko, V. S.,
and Kulikova, E. (2022) On an association between
fear- induced aggression and striatal-enriched protein
tyrosine phosphatase (STEP) in the brain of Norway
rats, Biomed. Pharmacother., 147, 112667, doi:10.1016/
j.biopha.2022.112667.
35. Arefieva, A. B., Komleva, P. D., Naumenko, V. S.,
Khotskin, N.V., and Kulikov, A.V. (2023) Invitro and
invivo chaperone effect of (R)-2-amino-6-(1R, 2S)-1,2-
dihydroxypropyl)-5,6,7,8-tetrahydropterin-4(3H)-one
on the C1473G mutant tryptophan hydroxylase 2,
Biomolecules, 13, 1458, doi:10.3390/biom13101458.
36. Kulikov, A.V., Osipova, D.V., and Popova, N.K. (2007)
The C1473G polymorphism in gene tph2 is the main
factor mediating the genetically defined variability of
tryptophan hydroxylase-2 activity in the mouse brain
[in Russian], Genetika, 43, 1676-1681.
Publisher’s Note. Pleiades Publishing remains
neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.